id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1994-E-0047-0001,FDA,FDA-1994-E-0047,Determination of Regulatory Review Period for Purposes of Patent Extension; Risperdal®,Notice,General Notice,1994-10-27T04:00:00Z,1994,10,1994-10-27T04:00:00Z,1994-11-01T04:59:59Z,2024-05-23T16:08:19Z,,0,0,09000064804ff746